Advertisement

Topics

Sumitomo Dainippon Pharma Co., Ltd. Strategy, SWOT and Corporate Finance Report [Report Updated: 02082017] Prices from USD $175

22:17 EDT 20 Sep 2017 | BioPortfolio Reports

Sumitomo Dainippon Pharma Co., Ltd. Strategy, SWOT and Corporate Finance Report

Summary

Sumitomo Dainippon Pharma Co., Ltd. Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate actions, providing a 360 view of the company.

Key Highlights

Sumitomo Dainippon Pharma SDP or 'the group' is a Japanbased global provider of pharmaceutical products. It is a subsidiary of Sumitomo Chemical. The group primarily operates in Asia and North America. It is headquartered in Osaka, Japan, and employed 6,697 people as of March 31, 2016.

Scope

Detailed information on Sumitomo Dainippon Pharma Co., Ltd. required for business and competitor intelligence needs
A study of the major internal and external factors affecting Sumitomo Dainippon Pharma Co., Ltd. in the form of a SWOT analysis
An indepth view of the business model of Sumitomo Dainippon Pharma Co., Ltd. including a breakdown and examination of key business segments
Intelligence on Sumitomo Dainippon Pharma Co., Ltd.'s mergers and acquisitions MandA, strategic partnerships and alliances, capital raising, private equity transactions, and financial and legal advisors
News about Sumitomo Dainippon Pharma Co., Ltd., such as business expansion, restructuring, and contract wins
Large number of easytograsp charts and graphs that present important data and key trends

Reasons to buy

Gain understanding of Sumitomo Dainippon Pharma Co., Ltd. and the factors that influence its strategies.
Track strategic initiatives of the company and latest corporate news and actions.
Assess Sumitomo Dainippon Pharma Co., Ltd. as a prospective partner, vendor or supplier.
Support sales activities by understanding your customers' businesses better.
Stay up to date on Sumitomo Dainippon Pharma Co., Ltd.'s business structure, strategy and prospects.

Original Article: Sumitomo Dainippon Pharma Co., Ltd. Strategy, SWOT and Corporate Finance Report [Report Updated: 02082017] Prices from USD $175

NEXT ARTICLE

More From BioPortfolio on "Sumitomo Dainippon Pharma Co., Ltd. Strategy, SWOT and Corporate Finance Report [Report Updated: 02082017] Prices from USD $175"

Advertisement
Quick Search
Advertisement
Advertisement

 

Relevant Topic

Biotechnology Business
Alliances Astrazeneca Bioethics Boehringer Clinical Research Organization Collaborations GSK Johnson & Johnson Lilly Merck Mergers and Acquisitions Nexium Novartis Pfizer Roche Sanofi ...